Literature DB >> 30258007

Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.

Peter Staeheli1,2, Otto Haller3,2,4.   

Abstract

Interferons limit viral replication by inducing intracellular restriction factors, such as the GTPase MxB (also designated MX2), which inhibits HIV-1 and, as recently shown, herpesviruses. Inhibition of these viruses occurs at ill-defined steps after viral entry and requires formation of MxB dimers or oligomers, but GTP hydrolysis is needed only for blocking herpesviruses. Together with previous findings on related MxA, the new research on MxB highlights the mechanistic diversity by which MX proteins interfere with viral replication.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; MX2; MxB; herpesviruses; interferons

Mesh:

Substances:

Year:  2018        PMID: 30258007      PMCID: PMC6258936          DOI: 10.1128/JVI.00709-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB.

Authors:  Megan C King; Graça Raposo; Mark A Lemmon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

2.  Systematic identification of type I and type II interferon-induced antiviral factors.

Authors:  Su-Yang Liu; David Jesse Sanchez; Roghiyh Aliyari; Sun Lu; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

3.  Role of MxB in Alpha Interferon-Mediated Inhibition of HIV-1 Infection.

Authors:  Bin Xu; Qinghua Pan; Chen Liang
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 4.  Mx GTPases: dynamin-like antiviral machines of innate immunity.

Authors:  Otto Haller; Peter Staeheli; Martin Schwemmle; Georg Kochs
Journal:  Trends Microbiol       Date:  2015-01-06       Impact factor: 17.079

5.  MXB inhibits murine cytomegalovirus.

Authors:  Ananda Ayyappan Jaguva Vasudevan; Ariane Bähr; Ramona Grothmann; Anna Singer; Dieter Häussinger; Albert Zimmermann; Carsten Münk
Journal:  Virology       Date:  2018-07-19       Impact factor: 3.616

6.  Oligomerization and GTP-binding Requirements of MxA for Viral Target Recognition and Antiviral Activity against Influenza A Virus.

Authors:  Patricia E Nigg; Jovan Pavlovic
Journal:  J Biol Chem       Date:  2015-10-27       Impact factor: 5.157

Review 7.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

8.  In vivo evasion of MxA by avian influenza viruses requires human signature in the viral nucleoprotein.

Authors:  Christoph M Deeg; Ebrahim Hassan; Pascal Mutz; Lara Rheinemann; Veronika Götz; Linda Magar; Mirjam Schilling; Carsten Kallfass; Cindy Nürnberger; Sébastien Soubies; Georg Kochs; Otto Haller; Martin Schwemmle; Peter Staeheli
Journal:  J Exp Med       Date:  2017-04-10       Impact factor: 14.307

9.  Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA.

Authors:  Patrick S Mitchell; Corinna Patzina; Michael Emerman; Otto Haller; Harmit S Malik; Georg Kochs
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

10.  Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.

Authors:  Caroline Goujon; Olivier Moncorgé; Hélène Bauby; Tomas Doyle; Wendy S Barclay; Michael H Malim
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

View more
  15 in total

1.  GTPase Activity of MxB Contributes to Its Nuclear Location, Interaction with Nucleoporins and Anti-HIV-1 Activity.

Authors:  Linlin Xie; Zhao Ju; Chaojie Zhong; Yingjun Wu; Yuxing Zan; Wei Hou; Yong Feng
Journal:  Virol Sin       Date:  2020-07-06       Impact factor: 4.327

2.  Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.

Authors:  Fengwen Xu; Fei Zhao; Xiaoxiao Zhao; Di Zhang; Xiaoman Liu; Siqi Hu; Shan Mei; Zhangling Fan; Yu Huang; Hong Sun; Liang Wei; Chao Wu; Quanjie Li; Jianwei Wang; Shan Cen; Chen Liang; Fei Guo
Journal:  J Biol Chem       Date:  2020-03-26       Impact factor: 5.157

Review 3.  HIV-1 restriction by SERINC5.

Authors:  Lucía Cano-Ortiz; Tom Luedde; Carsten Münk
Journal:  Med Microbiol Immunol       Date:  2022-03-25       Impact factor: 3.402

Review 4.  Tuning the Orchestra: HCMV vs. Innate Immunity.

Authors:  Valentina Dell'Oste; Matteo Biolatti; Ganna Galitska; Gloria Griffante; Francesca Gugliesi; Selina Pasquero; Alessandra Zingoni; Cristina Cerboni; Marco De Andrea
Journal:  Front Microbiol       Date:  2020-04-15       Impact factor: 5.640

5.  Subcellular Localization of MxB Determines Its Antiviral Potential against Influenza A Virus.

Authors:  Fiona Steiner; Jovan Pavlovic
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

6.  Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration.

Authors:  Andrea Henriques-Pons; Daniela Gois Beghini; Vanessa Dos Santos Silva; Samuel Iwao Horita; Fabrício Alves Barbosa da Silva
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

Review 7.  Herpes Simplex Virus 1 Infection of Neuronal and Non-Neuronal Cells Elicits Specific Innate Immune Responses and Immune Evasion Mechanisms.

Authors:  Amanda L Verzosa; Lea A McGeever; Shun-Je Bhark; Tracie Delgado; Nicole Salazar; Erica L Sanchez
Journal:  Front Immunol       Date:  2021-05-31       Impact factor: 8.786

Review 8.  HIV-1 Hijacking of Host ATPases and GTPases That Control Protein Trafficking.

Authors:  Lucas A Tavares; Yunan C Januário; Luis L P daSilva
Journal:  Front Cell Dev Biol       Date:  2021-07-08

Review 9.  Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway.

Authors:  José M Rojas; Alí Alejo; Verónica Martín; Noemí Sevilla
Journal:  Cell Mol Life Sci       Date:  2020-10-21       Impact factor: 9.261

Review 10.  Interactions of HIV-1 Capsid with Host Factors and Their Implications for Developing Novel Therapeutics.

Authors:  Shentian Zhuang; Bruce E Torbett
Journal:  Viruses       Date:  2021-03-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.